
宇興江,研究員,博士生導師
工作情況
單位:華中科技大學 同濟醫學院 88858cc永利官网組織學與胚胎學系
榮譽稱号:華中學者特聘教授,湖北省百人計劃入選者。
通訊地址:湖北省武漢市漢口航空路13号同濟醫學院88858cc永利官网形态樓7樓708
郵箱:yuxingjiang@hust.edu.cn /yuxingjiang@yahoo.com
研究方向
緻力于腦膠質瘤幹細胞緻病機理與臨床轉化研究。目前主要以腦膠質瘤幹細胞為對象,結合膠質瘤特征性的低氧微環境,從膠質瘤幹細胞代謝重編程及膠質瘤幹細胞與免疫細胞互作方面等探讨膠質瘤幹細胞的來源、自我更新能力的維持和分化潛能。尋找并鑒定新的膠質瘤生物學标記物和膠質瘤臨床治療新靶點,從中西醫結合的角度探索新的膠質瘤診療新策略。
目前實驗室已經建立起完整的低氧微環境研究體系,膠質瘤幹細胞篩選和培養系統,在腫瘤幹細胞自我更新能力的維持及分化、腫瘤代謝重編程、腫瘤幹細胞與腫瘤相關巨噬細胞互作、腫瘤細胞遷移與浸潤等研究方向積累了豐富經驗,課題組前期的工作已經篩選出一系列受低氧調控的新基因,并發現了一些基因在低氧狀态下的新功能,并鑒定若幹可能的膠質瘤臨床診療新策略。近年來,我們的一系列工作發表在Cell Stem Cell 2018(-Recommended article of high significance by Faculty of 1000 (F1000Prime Faculty).(IF:25.269 /Q1),Cancer Letters 2024(IF:9.8/Q1)Advanced Science(IF:15.1/Q1), Neuro-oncology(3篇)(IF:16.4/Q1), Theranostics 2篇(IF:12.4 /Q1),iScience 2022(IF:6.107 /Q1), Frontiers in Immunology 2022(IF:8.786 /Q1),Frontiers in Oncology 2022(IF:5.738 /Q2), Cell Reports 2021(IF:9.995 /Q1),Nature Communications 2020(IF:17.694 /Q1), Cancer Gene Theray 2020(IF:5.854 /Q1),等雜志上。并參編英文書籍Radiobiology Self-Assessment Guide, 由紐約Demos Medical出版社于2016年出版, 供放射科醫學生自學使用。這為以後的研究工作提供了堅實的理論基礎。
學術兼職
現為湖北省神經科學學會腦膠質瘤專業委員會副主任委員,中國解剖學會醫學發育生物學分會常委委員,中國歐美同學醫師協會神經膠質瘤分會學術委員會委員,中國解剖學會會員,湖北省解剖學會理事。
工作經曆
1.2019.09-至今華中科技大學同濟醫學院88858cc永利官网組織學與胚胎學系
研究領域:腫瘤幹細胞緻病機理和臨床轉化
研究方向:腫瘤幹細胞與腫瘤微環境互作及臨床轉化研究
2. 2015.06-2019.06博士後
Lerner research institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
研究領域:腫瘤幹細胞緻病機理和臨床轉化
研究方向:低氧環境對腫瘤幹細胞幹性維持的影響,
腫瘤幹細胞遷移與浸潤,
腫瘤幹細胞代謝與血管發生。
教育經曆
1.2009.09-2015.01博士 導師:李磊 研究員
中國科學院動物研究所,北京中國
研究領域:發育生物學
研究方向:早期胚胎發育與胚胎幹細胞
2.2005.09-2008.06碩士 導師:倪華副教授
東北農業大學,哈爾濱,中國
研究領域:基礎獸醫學
研究方向:胚胎着床的分子機制與調控
3.2000.09-2004.06學士
黑龍江大學,哈爾濱,中國
專業:生物技術
相關研究成果
1. Hongtao Zhu, Lidong Cheng, Dan Liu, Xiaoyu Ma, Zhiye Chen, Heng Fan, Ran Li, Yang Zhang, Hailong Mi, Jun Li, Suojun Zhang*, Xingjiang Yu*, and Kai Shu*,ROR1 facilitates glioblastoma growth via stabilizing GRB2 to promote c-Fos expression in glioma stem cells. Neuro-Oncology. 2024 Oct 24:noae224.doi: 10.1093/neuonc/noae224. (IF:16.4)
2. Zirong Chen,Junhong Wang,Peng Peng,Guohao Liu,Minhai Dong,Xiaolin Zhang,Yang Zhang,Xue Yang,Lijun Wan,Wang Xiang,Suojun Zhang,Bin Zhang,Qiuxia Wu*,Xingjiang Yu*,Feng Wan*,Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EphA2. Theranostics.2024 Sep 9;14(15):5778-5792.doi: 10.7150/thno.95141. eCollection 2024.(IF:12.4)
3.Yang Zhang,Tianxu Kang,Yuxi Wang,Chao Song,Huan Li,Hailong Mi,Yachao Li,Minhai Dong,Xiaoyu Ma,Hongtao Zhu,Lidong Cheng,Po Zhang,Zhiye Chen,Lin Zhou,Qiulian Wu,Feng Mao,Baofeng Wang,Suojun Zhang,Kai Shu,Feng Wan,Wenchao Zhou,Jeremy N Rich,Jianying Shen*,Qungen Xiao*,Xingjiang Yu*, Low level of tumor necrosis factor α in tumor microenvironment maintains self-renewal of glioma stem cells by Vasorin-mediated glycolysis. Neuro-Oncology. 2024 Aug 2:noae147. doi: 10.1093/neuonc/noae147. (IF:16.4)
4.Minhai Dong, Xiaolin Zhang, Peng Peng, Zirong Chen, Yang Zhang, Lijun Wan, Wang Xiang, Guohao Liu, Yang Guo, Qungen Xiao, Baofeng Wang, Dongsheng Guo, Min Zhu*, Xingjiang Yu*, Feng Wan*. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages. Cancer Letters. 2024 Mar 11:216801. (IF:9.8)
5.Dan Liu, Hongtao Zhu, Lidong Cheng, Ran Li, Xiaoyu Ma, Jing Wang, Junwen Wang, Suojun Zhang, Yingjie Li, Kai Shu*, Xingjiang Yu*, Chuanzhou Li*. Hypoxia induced Galectin-8 maintains stemness in glioma stem cells via autophagy regulation. Neuro-Oncology. 2023 Dec 30:noad264. doi: 10.1093/neuonc/noad264. (IF:16.4)
6. Huan Li, Chao Song, Yang Zhang, Guohao Liu, Hailong Mi, Yachao Li,Zhiye Chen, Xiaoyu Ma, Po Zhang, Lidong Cheng, Peng Peng, Hongtao Zhu, Zirong Chen, Minhai Dong, Sui Chen, Hao Meng, QunGen Xiao, Honglian Li, Qiulian Wu, Baofeng Wang, Suojun Zhang, Kai Shu, Feng Wan, Dongsheng Guo, Wenchao Zhou, Jeremy N. Rich*and Xingjiang Yu*. Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance through p53 Acetylation. Advanced Science. 2023 Dec 12:e2305620. (IF:15.1)
7. Guohao Liu#, Po Zhang#, Sui Chen, Zirong Chen, Yanmei Qiu, Peng Peng, Wenda Huang, Fangling Cheng, Yang Zhang, Huan Li, Qungen Xiao, Feng Mao, Baofeng Wang, Xiaobing Jiang, Feng Wan, Dongsheng Guo*, Xingjiang Yu*. FAM129A promotes self-renewal and maintains invasive status via stabilizing the notch intracellular domain in glioma stem cells. Neuro-Oncology. 2023 Oct 3;25(10):1788-1801.(IF:15.9)
8. Shihong Lv#, Zhiye Chen #, Hailong Mi, Xingjiang Yu*. Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma. Cancer Manag Res. 2022 Nov 24;14:3245-3269. (IF:3.602)
9. Guohao Liu #, Yanmei Qiu#, Po Zhang #, Zirong Chen, Sui Chen, Weida Huang, Baofeng Wang , Xingjiang Yu* and Dongsheng Guo*. Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies. Pharmaceutics 2022 Aug 24, 14, 1762. (IF:6.525)
10. Cuifang Ye, Huan Li, Yachao Li, Yang Zhang, Guohao Liu, Hailong Mi, Honglian Li, Qungen Xiao, Li Niu, and Xingjiang Yu#. Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE. iScience. 2022 Aug 4;25(9):104872. (IF:5.8)
11. Hongtao Zhu, Dan Liu, Lidong Cheng, Jingdian Liu, Guanghui Wang, Huan Li, Yang Zhang, Hailong Mi, Suojun Zhang, Kai Shu #, Xingjiang Yu#; Prognostic Value and Biological Function of Galectins in Malignant Glioma. Front Oncol.2022 Jun 24;12:834307. (IF:4.8)
12. Peng Peng, Hongtao Zhu, Dan Liu, Zirong Chen,Xiaolin Zhang, Zhongyin Guo, Minhai Dong, Lijun Wan, Po Zhang, Guohao Liu, Suojun Zhang, Fangyong Dong, Feng Hu, Fangling Cheng, Shijun Huang, Dongsheng Guo, Bin Zhang#, Xingjiang Yu#, Feng Wan#. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling. Theranostics 2022 May 16, Vol. 12, Issue 9. (IF:12.1)
13. Zhang Po*; Liu Guohao*; Hu Jinyang; Chen Sui; Wang Baofeng; Peng Peng; Yu Xingjiang#; Guo Dongsheng#; Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas. Frontiers in Immunology, 2022 Mar 16, 13. (IF:7.8)
14. Hongtao Zhu; Xingjiang Yu; Suojun Zhang; Kai Shu ; Targeting the Complement Pathway in Malignant Glioma Microenvironments. Front Cell Dev Biol., 2021 Apr 1, 9( 657472) .(IF:6.081)
15. Weiwei Tao, Chengwei Chu, Wenchao Zhou, Zhi Huang, Kui Zhai, Xiaoguang Fang, Qian Huang, Aili Zhang, Xiuxing Wang, Xingjiang Yu, Haidong Huang, Qiulian Wu, Andrew E. Sloan, Jennifer S. Yu, Xiaoxia Li, George R. Stark, Jeremy N. Rich & Shideng Bao*. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma. Nature Communcations. 2020 Jun 15;11(1):3015. (IF:17.694)
16. Minhai Dong #, Qungen Xiao #, Jinyang Hu, Fangling Cheng, Po Zhang, Weifeng Zong, Qiaoying Tang, Xiaopeng Li, Feng Mao, Yue He, Xingjiang Yu, Feng Wan, Ting Lei, Dongsheng Guo, Baofeng Wang. Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling. Cancer Gene Theray.2020 Jan 28. (IF:5.854)
17. Haidong Huang; Xingjiang Yu; Xiangzi Han; Jing Hao; Jianjun Zhao; Gurkan Bebek; Shideng Bao; Richard A. Prayson; Ahmad M. Khalil; Eckhard Jankowsky; Jennifer S. Yu ; Piwil1 Regulates Glioma Stem Cell Maintenance and Glioblastoma Progression, Cell Reports, 2021, 34(1). (IF:9.995)
18. Jianghong Man#; Xingjiang Yu#; Haidong Huang; Wenchao Zhou; Chaomei Xiang; Haohao Huang; Lucio Miele; Zhenggang Liu; Gurkan Bebek; Shideng Bao; Jennifer S. Yu* ; Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells, Cell Stem Cell, 2018 Jan, 22(1): 1-15. (IF:25.269)
19. Zheng Gao, Xiaoxin Zhang, Xingjiang Yu, Dandan Qin, Yi Xiao, Yang Yu, Yunlong Xiang, Xiaoqing Nie, Xukun Lu, Wenbo Liu, Zhaohong Yi, Lei Li*. Zbed3 participates in the subcortical maternal complex and regulates the distribution of organelles. J Mol Cell Biol. 2017 Aug 23. (IF:8.185)
20. Yusheng Liu, Xukun Lu, Junchao Shi, Xingjiang Yu, Xiaoxin Zhang, Kai Zhu, Zhaohong Yi, Enkui Duan, Lei Li* . BTG4 is a key regulator for maternal mRNA clearance during mouse early embryogenesis. J Mol Cell Biol. 2016 Aug;8(4):366-8. (IF:8.185)
21. Qianhua Xu#, Fengchao Wang#, Yunlong Xiang, Xiaoxin Zhang, Zhen-Ao Zhao, Zheng Gao, Wenbo Liu, Xukun Lu, Yusheng Liu, Xing-Jiang Yu, Haibin Wang, Jun Huang, Zhaohong Yi, Shaorong Gao*, Lei Li*. Maternal BCAS2 protects genomic integrity in mouse early embryonic development. Development. 2015 Nov 15;142(22):3943-53. (IF:6.862)
22. Xingjiang Yu; Zhaohong Yi; Zheng Gao; Dandan Qin; Yanhua Zhai; Xue Chen; Yingchun Ou-Yang; Zhen-Bo Wang; Ping Zheng; Min-Sheng Zhu; Haibin Wang; Qing-Yuan Sun; Jurrien Dean; Lei Li ; The subcortical maternal complex controls symmetric division of mouse zygotes by regulating F-actin dynamics. Nature Communications, 2014 Sep 11, 5(4887): 1-12. (IF:17.694)
23. Hua Ni, Xing-Jiang Yu, Hua-Jie Liu, Wei Lei, Deivendran Rengaraj, Xiao-Juan Li, Zeng-Ming Yang. Progesterone regulation of glutathione S-transferase Mu2 expression in mouse uterine luminal epithelium during preimplantation period. Fertil and Steril. 2009 May;91(5 Suppl):2123-30. (IF:7.490)
專著
Radiobiology Self-Assessment Guide, Demos Medical, 2016. Mohamed E.Abazeed; Alex Almasan; Sudha Amarnath; Marc Apple; Ehsan H. Balagamwala; Salim Balik; Elia Bar; Camille Berriochoa; HyeonJoo Cheon; Taoran Cui; Sharvari Dharmaiah; Frank Dong; Andrew Godley; John F. Greskovich; Haidong Huang; Nikhil Joshi; Aditya Juloori; Jeffrey A.Kittel; Susan Kost; Daesung Lee; C.Marc Leyrer; Bindu V. Manyam; Anthony Mastroianni; Mihir Naik; Steven Oh; Yvonne Pham; Peng Qi; Vinay Rao; Richard Blake Ross; Chirag Shah; Matthew C.Ward; Michael A,Weller; Neil Woody; Kevin Wunderle; Choamei Xiang; Kailin Yang; Brian D.Yard; Jennifer S. Yu;Xingjiang Yu. (學術專著)
專利
申請國家發明專利一項。
發明創造名稱:一種抗惡性膠質瘤的藥物組合物及其在制備抗腫瘤藥劑中的應用
申請号或專利号:202311415243.7
獲獎列表
2019年湖北省“百人計劃”獲得者
2014年國家獎學金獲得者
主持或參與的基金項目列表
1. 國家自然科學基金委員會,面上項目,82473132, 低氧微環境下内質網相關蛋白SURF4誘導液液相分離促進膠質瘤幹細胞自我更新的機制研究, 2025.01.01至2028.12.31,49萬,在研,主持。
2.華中科技大學前沿學術團隊項目 2021.01.01-2025.12.31 ,100萬,在研。
3. 華中科技大學自主創新基金,2019kfyXJJS187,膠質母細胞瘤幹細胞的緻病與治療機制及轉化應用研究,2019.01.01-2021.12.31,100萬,已結題,主持。
4. 國家自然科學基金委員會,面上項目,81974452,低氧調節因子Vasorin對膠質瘤幹細胞遷移和浸潤的影響,2020.01.01至2023.12.31,55萬,已結題,主持。
5. 國家自然科學基金面上項目,31471353,蛋白複合體新組分SCMC5的鑒定、功能和分子作用機制研究,2015.01-2018.12,88萬,已結題,參加
6. 國家自然科學基金面上項目,31171382,BCAS2在小鼠早期胚胎發育過程中的生理功能及分子作用機制,2012.01-2015.12,70萬,已結題,參加
7. 國家重大科學研究計劃,2011CB944501,“雌性生殖細胞發生、發育和成熟的分子調節機制”,2011/01-2015/08,329萬,已結題,參加
8. 國家自然科學基金面上項目,30971655,TLE6 在哺乳動物早期胚胎發育過程中的生理功能的研究,2010.01-2012.12,32萬,已結題,參加